| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 03/22/2007 | WO2007031390A1 Process for the preparation of contrast agents |
| 03/22/2007 | US20070066846 Process for making (S)-Pregabalin |
| 03/22/2007 | US20070066843 Process for the preparation of gabapentin |
| 03/22/2007 | DE102005044090A1 Preparing beta-aminopropionic acid derivative, useful as hardener, comprises reacting amine with acrylic acid to give beta-aminopropionic acid and unreacted acrylic acid derivative; and reacting obtained acid derivative with amine |
| 03/21/2007 | EP1763503A1 4-t-butylgabapentin and its synthesis |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | CN1934069A 氨基酸衍生物 Amino acid derivatives |
| 03/21/2007 | CN1934066A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 03/21/2007 | CN1934065A Processes for the preparation of iodinated amino-aryl compounds |
| 03/21/2007 | CN1931828A Prepn process of amino acid-calcium chelate |
| 03/21/2007 | CN1305836C Method for preparing glycine |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7193103 Reacting an admixture of N-(3,3-dimethylbutyl)-L-aspartic acid and a ketone or an acetal of a ketone in a first solvent for a time and at a temperature sufficient to produce an oxazolidinone derivative, reacting with L-phenylalanine or L-phenylalanine methyl ester in a second solvent |
| 03/20/2007 | US7193041 Method for purification of recombinant proteins |
| 03/20/2007 | CA2411787C Stable gabapentin having ph within a controlled range |
| 03/15/2007 | US20070060497 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 03/14/2007 | EP1762563A1 Process for the preparation of contrast agents |
| 03/14/2007 | EP1761479A1 Process for preparing amino acids using the amidocarbonylation reaction |
| 03/14/2007 | EP1606242B1 Azide free process for preparing 1,2-diamino compounds |
| 03/14/2007 | EP1565433B1 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/14/2007 | EP1526917B1 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 03/14/2007 | EP1054893B1 Synthetic polymers and methods, kits or compositions for modulating the solubility of same |
| 03/14/2007 | CN1927816A Method of preparing D-alanine by asymmetric transition method |
| 03/14/2007 | CN1304364C Bionic method for synthesizing alpha cycloalanine |
| 03/14/2007 | CN1304363C N-methyl-homocysteines and their use as well as process for their production |
| 03/14/2007 | CN1304362C Prepn process of metal-amino acid chelate |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189865 Thiomolybdate analogues and uses thereof |
| 03/13/2007 | US7189857 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/13/2007 | US7189848 Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation |
| 03/13/2007 | US7189847 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 03/08/2007 | US20070054960 Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride form II |
| 03/07/2007 | EP1758859A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1397372A4 Water-soluble polymeric metal ion affinity compositions and methods for using the same |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | CN1926240A Biochemical synthesis of 6-amino caproic acid |
| 03/07/2007 | CN1926078A Process for recovering organic compounds from aqueous streams containing same |
| 03/07/2007 | CN1923799A Method of recovering o-aminobenzoic acid from mother liquid or waste water |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 03/07/2007 | CN1303058C Process for preparation of biodegradable corrosion-scale inhibitor amino poly-apoxysuccinic acid |
| 03/07/2007 | CN1303057C Synthesis method of L-aspartic acid-beta-benzylester |
| 03/07/2007 | CN1303056C Synthesis process of 15 N-glycine |
| 03/06/2007 | US7186859 Uses for amino acid anticonvulsants |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186704 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 03/06/2007 | US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/01/2007 | WO2006108151A9 Crystalline forms of pregabalin |
| 03/01/2007 | WO2006104826A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 03/01/2007 | WO2005110396A3 Nitrated lipids and methods of making and using thereof |
| 03/01/2007 | US20070049637 Process for the synthesis of cationic lipids |
| 02/28/2007 | EP1757670A2 Organic electroluminescent element |
| 02/28/2007 | EP1757568A1 Method of labeling with isotope of oxygen |
| 02/28/2007 | EP1756038A1 Synthesis of amino-alkoxy-heptanoic alkyl ester |
| 02/28/2007 | EP1756036A1 Indene derivatives and process for the preparation thereof |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
| 02/28/2007 | CN1919201A Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301963C Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 02/28/2007 | CN1301962C Production of keto acids |
| 02/27/2007 | US7183433 Ionic liquids and their use as solvents |
| 02/27/2007 | US7183429 Salt formation by reacting ammonium with a mixture of maleic anhydride, alkali metal hydroxide and water, then reacting with metal oxides, metal hydroxides; use as trace element fertilizers or slug and snail pellets in agriculture |
| 02/27/2007 | US7183426 T-butyl cascade polymers |
| 02/27/2007 | US7183425 Ketones or ketals are combined with alpha-aminoesters under basic conditions to form metal carboxylates; reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions; intermediates to selective cathepsin K inhibitors for osteoarthritis or osteoporosis |
| 02/27/2007 | US7183317 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 02/27/2007 | US7183240 Additives for inhibiting the formation of gas hydrates |
| 02/22/2007 | WO2007020973A1 Method of recovering carnitine |
| 02/22/2007 | WO2007019752A1 Process for the preparation of gabapentin hydrochloride |
| 02/22/2007 | US20070043237 Obtaining gabapentin form II directly from an aqueous gabapentin hydrochloride solution; purification by treatment with a strong cationic ion exchange resin |
| 02/22/2007 | US20070043236 Process for preparation of gabapentin |
| 02/22/2007 | US20070043219 Cis and trans configurations of these chemical intermediates for insecticides, miticides, and herbicides or drugs; prepared using water as solvent to form a hydrolyzable spirohydantoin from a 4-alkylcyclohexanone |
| 02/22/2007 | US20070043191 (Meth)acrylic acid esters of unsaturated aminoalcohols and preparation thereof |
| 02/22/2007 | US20070043104 UII-modulating compounds and their use |
| 02/21/2007 | CN1917870A Compounds and compositions as lxr modulators |
| 02/21/2007 | CN1915966A Derivative of new type menthol, preparation method and application |
| 02/20/2007 | US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes |
| 02/20/2007 | US7179934 4R,5R)-3-amino-4,5-dimethyl-hept-2-(Z)-enoic acid ethyl ester;analgesic, antipsychotic |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | CA2404700C Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 02/15/2007 | WO2007017610A2 Cosmetic composition comprising at least one fatty-chain polylysine, which is intended to improve the surface state of keratin fibres |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/14/2007 | EP1751297A2 Biosynthetic production of 4-amino-4-deoxychorismate (adc) and [3,4r]-4-amino-3-hydroxycyclohexa-1,5-diene-1-carboxylic acid (3,4-cha) |
| 02/14/2007 | EP1751206A2 Polyurea compositions and compounds for the preparation thereof |
| 02/14/2007 | EP1751096A2 Salt of 4- or 5- aminosalicylic acid |
| 02/14/2007 | EP1751087A1 Levodopa prodrugs, and compositions and uses thereof |
| 02/14/2007 | EP1750721A1 Topical cromolyn formulations |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | EP1368336B9 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | CN1911900A Method for preparing aminotrisodium acetate using by product hydrocyanic acid of acrylonitrile device |
| 02/14/2007 | CN1300102C Synthesis method of valine crystallizing agent |
| 02/14/2007 | CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/08/2007 | US20070031326 Compounds that selectively bind to membranes of apoptotic cells |
| 02/07/2007 | EP1749870A1 Fluorescein-based compounds and their use for peptide synthesis |